No Detail Found!

Alantolactone inhibits A2780 cell growth through glycolysis inhibition and ros-induced apoptosis and overcomes cisplatin resistance

Author(s)
Chenchen Liu School of Medicine and Holistic Integrative Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, P.R. China; College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, P.R. China
Tong Wang School of Medicine and Holistic Integrative Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, P.R. China
Muhammad Khan Department of Zoology, University of the Punjab,Quaid-e-Azam Campus Lahore 54590,Pakistan
Xiaolin Cui College of Basic Medical Sciences, Dalian Medical University,Dalian 116044,P.R. China
Yongming Li School of Medicine and Holistic Integrative Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, P.R. China; College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, P.R. China
Abstract
Alantolactone (ALT) a biologically active sesquiterpene lactone compound has been shown to exhibit anticancer activity against a series of human cancers through multiple mechanism. However, the anticancer effects of ALT against ovarian cancer remains unknown. Here, we report that ALT inhibits growth and induces apoptosis in parental and cisplatin-resistant ovarian cancer cells. Growth inhibitory effects of ALT are evident from CCK-8, Edu, and colonogenic assays. The molecular mechanism associated with induction of apoptosis includes ROS generation, G2/M phase arrest and inhibition of aerobic glycolysis. Inhibition of glycolysis was found to be linked with down-regulation of lactate dehydrogenase A (LDHA) and glucose transporter-1 (GLUT1). Finally, ALT effectively suppressed growth and induced apoptosis in cisplatin resistant A2780/CR cells. Taken together, our findings suggest that ALT could be developed into a lead for effective treatment of ovarian cancer.
Publication Details
Page(s) 1199-1206
Published Journal: Pakistan Journal of Zoology, Volume: 55, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Ovarian cancer, Apoptosis, Glycolysis, Alantolactone, G2/M phase arrest
0

Citations

0

Downloads

183

Views